BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21850565)

  • 1. Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata: results of symptom control and health-related quality of life 40 months after treatment.
    Froeling V; Scheurig-Muenkler C; Hamm B; Kroencke TJ
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):523-9. PubMed ID: 21850565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term durability of uterine artery embolisation for treatment of symptomatic adenomyosis.
    Ma J; Brown B; Liang E
    Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):290-296. PubMed ID: 33583017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome prediction for symptomatic patients with fibroids who underwent uterine artery embolization.
    Wu Q; Motaghi M; Tang H; Hazhirkarzar B; Shaghaghi M; Ghadimi M; Baghdadi A; Rezvani R; Mohseni A; Borhani A; Madani SP; Afyouni S; Zandieh G; Kamel IR
    Clin Imaging; 2024 Jan; 105():110028. PubMed ID: 38039750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing magnetic resonance imaging and ultrasound in the clinical evaluation of fibroids prior to uterine artery embolization.
    Medema AM; Zanolli NC; Cline B; Pabon-Ramos W; Martin JG
    Curr Probl Diagn Radiol; 2024; 53(2):308-312. PubMed ID: 38267343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus.
    Kröncke T
    Br J Radiol; 2023 Mar; 96(1143):20220121. PubMed ID: 36222200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8Spheres conformal microspheres as embolic agents for symptomatic uterine leiomyoma therapy in uterine artery embolization (UAE): A prospective clinical trial.
    Zhang Y; Xu Y; Zhang X; Zheng B; Hu W; Yuan G; Si G
    Medicine (Baltimore); 2023 Mar; 102(9):e33099. PubMed ID: 36862859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life Quality in Premenopausal Women after Embolization of Uterine Myomas.
    Tsikouras P; Gkaitatzi F; Gerede A; Anthoulaki X; Bothou A; Chalkidou A; Michalopoulos S; Tsirkas I; Gyroglou S; Peitsidis P; Nikolettos K; Alexiou A; Dragoutsos G; Sachnova N; Chloropoulou P; Zervoudis S; Iatrakis G; Rath W; Trypsiannis G; Nikolettos N; Souftas V
    J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556210
    [No Abstract]   [Full Text] [Related]  

  • 8. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry.
    Anchan RM; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL; Spies JB
    J Womens Health (Larchmt); 2023 Apr; 32(4):423-433. PubMed ID: 36637808
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of normalization of postoperative carbohydrate antigen 125 levels with treatment failure following uterine artery embolization for adenomyosis.
    Liu S; Peng C; Wang Z; Zhou X; Zhang S; Li G; Yang B
    J Obstet Gynaecol Res; 2023 Nov; 49(11):2753-2760. PubMed ID: 37614048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ROLE OF UTERINE ARTERY EMBOLIZATION IN ORGAN-PRESERVING TREATMENT OF ADENOMYOSIS (REVIEW)].
    Bakhtiyarov K; Bobrov B; Lubnin D; Volkova P
    Georgian Med News; 2022 Feb; (323):30-37. PubMed ID: 35271468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of adenomyosis, abdominal wall endometriosis and uterine leiomyoma with interventional radiology: A review of current evidences.
    Barat M; Dohan A; Kohi M; Marcelin C; Pelage JP; Denys A; Mafeld S; Kaufman CS; Soyer P; Cornelis FH
    Diagn Interv Imaging; 2024 Mar; 105(3):87-96. PubMed ID: 38065817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine artery embolization in Tanzania: a procedure with major public health implications.
    Musa B; Alswang JM; Di Ioia R; Grubic L; Naif A; Mbuguje EM; Vuong V; Newsome J; Shaygi B; Ramalingam V; Gaupp FML
    CVIR Endovasc; 2023 Aug; 6(1):40. PubMed ID: 37548779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Recurrence and Reintervention After Uterine-Sparing Interventions for Symptomatic Adenomyosis: A Systematic Review and Meta-Analysis.
    Liu L; Tian H; Lin D; Zhao L; Wang H; Hao Y
    Obstet Gynecol; 2023 Apr; 141(4):711-723. PubMed ID: 36897132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extravascular Dispersion of Polyvinyl Alcohol Microsphere Particles in Uterine Artery Embolization.
    Torres-de la Roche LA; Cezar C; Hanif S; Devassy R; Krentel H; Hennefründ J; De Wilde RL
    Biomed Res Int; 2022; 2022():7426210. PubMed ID: 35211624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years.
    Tsikouras P; Oikonomou E; Tsatsaris G; Bothou A; Kyriakou D; Nikolettos K; Nalmbanti T; Peitsidis P; Trypsanis G; Iatrakis G; Nikolettos N; Souftas V
    J Pers Med; 2023 Sep; 13(9):. PubMed ID: 37763151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine artery embolisation: fertility, adenomyosis and size - what is the evidence?
    Mailli L; Patel S; Das R; Chun JY; Renani S; Das S; Ratnam L
    CVIR Endovasc; 2023 Feb; 6(1):8. PubMed ID: 36847951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine Artery Embolization for Symptomatic Adenomyosis: Proceedings from a Society of Interventional Radiology Foundation Research Consensus Panel.
    Caridi TM; De la Garza-Ramos C; Brook OR; Learman LA; Opoku-Anane J; Phipps D; Ascher SM; Lipman JC; Lohle PNM; Halvorson LM; Abi-Jaoudeh N; Kohi MP
    J Vasc Interv Radiol; 2022 May; 33(5):586-592. PubMed ID: 35489788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine artery embolization with highly compressible calibrated microspheres for the treatment of uterine fibroids.
    Szejnfeld D; Santos RFT; Kambara AM; Colli MBO; Nasser F; Martins MS; Goldman SM
    Radiol Bras; 2022; 55(4):231-235. PubMed ID: 35983349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Transabdominal Ultrasound-guided Percutaneous Microwave Ablation in the Treatment of Symptomatic Adenomyosis: A Retrospective Cohort Study.
    Li S; Li Z; Lin M; Li X; Gao L; Qiu J; He J; Zhang J; Lyu G
    J Minim Invasive Gynecol; 2023 Feb; 30(2):137-146. PubMed ID: 36384213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy.
    Taran FA; Stewart EA; Brucker S
    Geburtshilfe Frauenheilkd; 2013 Sep; 73(9):924-931. PubMed ID: 24771944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.